Further studies should examine the expressions of CD47 and CD24 at the transcriptional levels to further understand the mechanism of CD47/SIRPα and CD24/Siglec‐1 pathways in the anti‐tumor immune response. The gene discussed is SIGLEC1; the disease is neoplasm.